In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
Detection decisions (red for absence, blue for presence) are based on the disjunctive integration rule (disjunction and negation of disjunction). Confidence decisions (dashed line for not sure, full ...
The ability to make adaptive decisions in uncertain environments is a fundamental characteristic of biological intelligence. Historically, computational ...
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores the urgent need to scale up newborn and early childhood screening, ...
Background A regional trial indicated that implementing at-risk asthma registers in primary care could reduce hospital ...
Analysis of scRNA-seq data from primate embryoid bodies highlights the value of cross-species comparisons for identifying and characterizing cell types, as marker genes can evolve fast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results